3/9/26 07:05 | 3/6/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weaver Gregory L | MD | O | CFO | 1 | P | 18 | 3.54 | 0 | 5 | 22 | 28 | D | | | | | | | | | | | | | | |
3/9/26 07:00 | 3/6/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Durso Jerome Benedict | MD | DO | P,CEO | 2 | P | 122 | 3.76 | 0 | 33 | | 33 | D | | | | | | | | | | | | | | |
3/6/26 21:31 | 3/5/26 | BFRI | Biofrontera Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luebbert Hermann | MA | DO | CEO,CB | 1 | M.d | 0 | 0.00 | 0 | 138 | 90 | 290 | D | | | | | | | | | | | | | | |
3/6/26 21:30 | 3/5/26 | BFRI | Biofrontera Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leffler Eugene Frederick | MA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 88 | 100 | 175 | D | | | | | | | | | | | | | | |
3/6/26 19:27 | 12/16/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 3 | M.dm | 346 | 7.54 | 0 | 46 | 16 | 339 | D | | | | | | | | | | | | | | |
3/6/26 19:18 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dier Mardi | PA | O | EVP,CFO | 2 | S.d | -1,359 | 429.50 | 0 | -3 | | 12 | D | | | | | | | | | | | | | | |
3/6/26 18:56 | 3/5/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Jennifer | MA | O | GC | 2 | M.d | 410 | 19.98 | 0 | 21 | | 0 | D | | | | | | | | | | | | | | |
3/6/26 18:56 | 3/5/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Jennifer | MA | O | GC | 2 | S.d | -410 | 19.98 | 0 | -21 | -100 | 0 | D | | | | | | | | | | | | | | |
3/6/26 18:51 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 2 | M.d | 1,293 | 129.31 | 0 | 10 | 37 | 37 | D | | | | | | | | | | | | | | |
3/6/26 18:51 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 2 | S.d | -1,293 | 129.31 | 0 | -10 | | 37 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 4 | M.d | 3,398 | 172.68 | 0 | 20 | 221 | 29 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 4 | S.d | -3,398 | 172.68 | 0 | -20 | | 29 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sibold William John | PA | DO | P,CEO | 2 | S.d | -1,495 | 461.38 | 0 | -3 | | 162 | D | | | | | | | | | | | | | | |
3/6/26 18:34 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelley Shannon T | PA | O | GC | 2 | S.d | -500 | 474.97 | 0 | -1 | | 12 | D | | | | | | | | | | | | | | |
3/6/26 18:15 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Huntsman Carole | PA | O | Chief Co | 2 | S.d | -630 | 474.28 | 0 | -1 | | 13 | D | | | | | | | | | | | | | | |
3/6/26 18:07 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taub Rebecca | PA | D | | 9 | S.d | -22,265 | 285.54 | 0 | -78 | | 1,111 | D | | | | | | | | | | | | | | |
3/6/26 17:29 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Herman Jenny | NY | O | CAO | 2 | S.m | -28 | 13.18 | 0 | -2 | | 35 | D | | | | | | | | | | | | | | |
3/6/26 17:29 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jain Rachit | NY | O | EVP,CFO | 1 | S | -21 | 12.90 | 0 | -2 | | 53 | D | | | | | | | | | | | | | | |
3/6/26 17:28 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tran Yvonne | NY | O | EVP, CLO | 2 | S | -25 | 13.27 | 0 | -2 | | 53 | D | | | | | | | | | | | | | | |
3/6/26 17:28 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Farid Ramy | NY | DO | P,CEO | 1 | S | -47 | 12.91 | 0 | -4 | | 331 | D | | | | | | | | | | | | | | |
3/6/26 17:27 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akinsanya Karen | NY | O | See Rema | 1 | S | -18 | 12.90 | 0 | -1 | | 70 | D | | | | | | | | | | | | | | |
3/6/26 17:26 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lorton Kenneth Patrick | NY | O | EVP,CTO, | 2 | S | -28 | 13.26 | 0 | -2 | | 89 | D | | | | | | | | | | | | | | |
3/6/26 17:26 | 3/4/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abel Robert Lorne | NY | O | See Rema | 2 | S | -33 | 13.15 | 0 | -3 | | 56 | D | | | | | | | | | | | | | | |
3/6/26 17:07 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | DO | CEO,MD | 3 | S.d | -770 | 12.54 | 0 | -61 | | 661 | D | | | | | | | | | | | | | | |
3/6/26 17:05 | 3/4/26 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Purdue David Ryan | IL | O | SVP,Cont | 1 | S | -1,222 | 233.56 | 0 | -5 | | 3 | D | | | | | | | | | | | | | | |
3/6/26 17:01 | 3/5/26 | EDSA | Edesa Biotech, Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Nijhawan Pardeep | A6 | DOT | CEO | 5 | P.m | 223 | 2.67 | 0 | 84 | 8 | 1,148 | I | | | | | | | | | | | | | | |
3/6/26 16:59 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Abi-Saab Walid | | O | Chief Me | 2 | S.d | -24 | 9.66 | 0 | -2 | | 190 | D | | | | | | | | | | | | | | |
3/6/26 16:57 | 3/4/26 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | 2 | M.d | 4,760 | 36.66 | 0 | 130 | | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:57 | 3/4/26 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | 2 | S.d | -4,760 | 36.66 | 0 | -130 | | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:55 | 3/4/26 | GENB | Generate Biomedicines, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nally Michael | MA | DO | CEO | 1 | P | 240 | 12.00 | 0 | 20 | 1 | 2,889 | D | | | | | | | | | | | | | | |
3/6/26 16:51 | 3/4/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 4 | M.d | 530 | 44.56 | 0 | 12 | | 4 | D | | | | | | | | | | | | | | |
3/6/26 16:51 | 3/4/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 4 | S.d | -530 | 44.56 | 0 | -12 | | 4 | D | | | | | | | | | | | | | | |
3/6/26 16:36 | 3/4/26 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wentworth Kory James | MA | O | CFO | 1 | S | -98 | 12.25 | 0 | -8 | | 138 | D | | | | | | | | | | | | | | |
3/6/26 16:35 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Potts Jeannette | | O | GC | 2 | S.d | -116 | 9.70 | 0 | -12 | | 138 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 6 | M.d | 2,862 | 29.66 | 0 | 96 | | 2 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 6 | S.d | -2,862 | 29.66 | 0 | -96 | | 2 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Klemt Christian | P7 | O | CFO | 3 | S.d | -382 | 12.42 | 0 | -31 | | 227 | D | | | | | | | | | | | | | | |
3/6/26 16:26 | 3/5/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Edmondson Frazor Titus III | MA | O | GC | 2 | S | -445 | 18.37 | 0 | -24 | | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:25 | 3/4/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | 2 | M.dm | 2,093 | 10.47 | 0 | 200 | 26 | 964 | D | | | | | | | | | | | | | | |
3/6/26 16:25 | 3/4/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | 2 | S.dm | -2,093 | 10.47 | 0 | -200 | | 964 | D | | | | | | | | | | | | | | |
3/6/26 16:19 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | 6 | M.d | 30,418 | 11.25 | 0 | 2,705 | | 1,148 | D | | | | | | | | | | | | | | |
3/6/26 16:19 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | 6 | S.d | -30,418 | 11.25 | 0 | -2,705 | | 1,148 | D | | | | | | | | | | | | | | |
3/6/26 16:17 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | 6 | M.d | 12,593 | 17.76 | 0 | 709 | | 123 | D | | | | | | | | | | | | | | |
3/6/26 16:17 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | 6 | S.d | -12,593 | 17.76 | 0 | -709 | | 123 | D | | | | | | | | | | | | | | |
3/6/26 16:14 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | Streck Paul | MA | O | EVP,Head | 1 | S | -12 | 6.23 | 0 | -2 | | 76 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Garg Pushkal | MA | O | EVP Chie | 6 | S.dm | -5,431 | 293.70 | 0 | -18 | | 26 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Greenstreet Yvonne | MA | DO | CEO | 5 | S.d | -8,808 | 273.64 | 0 | -32 | | 99 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | 4 | M.d | 8,440 | 15.23 | 0 | 554 | | 271 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Poulton Jeffrey V. | MA | O | EVP,CFO | 5 | S.d | -3,224 | 277.85 | 0 | -12 | | 64 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Tanguler Tolga | MA | O | EVP,Chie | 5 | S.d | -2,425 | 268.19 | 0 | -9 | | 37 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donnelly Noel | MA | O | CFO | 1 | S | -13 | 6.23 | 0 | -2 | | 112 | D | | | | | | | | | | | | | | |
3/6/26 16:11 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | 4 | S.dm | -4,150 | 336.31 | 0 | -12 | | 22 | D | | | | | | | | | | | | | | |
3/6/26 16:10 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 1 | S | -2 | 14.90 | 0 | 0 | 0 | 155 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | 4 | M.d | 2,980 | 10.58 | 0 | 282 | | 98 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | 4 | S.d | -2,980 | 10.58 | 0 | -282 | | 98 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | McArthur James G | MA | DO | P,CEO | 1 | S | -33 | 6.23 | 0 | -5 | | 296 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 1 | S | -13 | 14.90 | 0 | -1 | | 172 | D | | | | | | | | | | | | | | |
3/6/26 16:08 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | 3 | M.d | 11,635 | 19.59 | 0 | 594 | | 306 | D | | | | | | | | | | | | | | |
3/6/26 16:08 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 1 | S | -41 | 14.90 | 0 | -3 | | 446 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | 2 | M.d | 295 | 9.99 | 0 | 30 | 65 | 75 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | 2 | S.d | -295 | 9.99 | 0 | -30 | | 75 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McKechnie Duncan | MA | O | EVP,Chie | 2 | S | -3,553 | 483.55 | 0 | -7 | | 18 | D | | | | | | | | | | | | | | |
3/6/26 16:03 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | 4 | M.d | 128 | 8.20 | 0 | 16 | | 8 | D | | | | | | | | | | | | | | |
3/6/26 16:03 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | 4 | S.d | -128 | 8.20 | 0 | -16 | | 8 | D | | | | | | | | | | | | | | |
3/6/26 16:01 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Weiss Amir | L3 | O | Chief Ac | 3 | M.d | 372 | 10.99 | 0 | 34 | | 27 | D | | | | | | | | | | | | | | |
3/6/26 09:00 | 3/4/26 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morris Shannon | CA | O | Chief Me | 2 | M.d | 335 | 8.37 | 0 | 40 | | 0 | D | | | | | | | | | | | | | | |
3/6/26 09:00 | 3/4/26 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morris Shannon | CA | O | Chief Me | 2 | S.d | -335 | 8.37 | 0 | -40 | -100 | 0 | D | | | | | | | | | | | | | | |
3/6/26 07:28 | 3/5/26 | PMN | Promis Neurosciences Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Williams Eugene | A6 | D | | 2 | P.m | 141 | 23.54 | 0 | 6 | 94 | 12 | D | | | | | | | | | | | | | | |
3/5/26 20:00 | 3/3/26 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mitchell Shawnte | CA | O | GC | 2 | M.dm | 1,126 | 14.08 | 0 | 80 | | 0 | D | | | | | | | | | | | | | | |
3/5/26 20:00 | 3/3/26 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mitchell Shawnte | CA | O | GC | 2 | S.dm | -1,126 | 14.08 | 0 | -80 | -100 | 0 | D | | | | | | | | | | | | | | |
3/5/26 19:18 | 3/5/26 | XERS | Xeris Biopharma Holdings, Inc. | | Health | Drug | Pharmaceutical Preparations | Pieper Steven | IL | O | See Rema | 1 | M.d | 197 | 4.71 | 0 | 42 | 3 | 1,409 | D | | | | | | | | | | | | | | |
3/5/26 19:10 | 12/15/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 9 | M.d | 889 | 10.28 | 0 | 87 | 68 | 214 | D | | | | | | | | | | | | | | |
3/5/26 19:10 | 12/15/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 9 | S.d | -889 | 10.28 | 0 | -87 | | 214 | D | | | | | | | | | | | | | | |
3/5/26 19:08 | 12/22/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 6 | M.dm | 608 | 11.02 | 0 | 55 | 61 | 145 | D | | | | | | | | | | | | | | |
3/5/26 19:08 | 12/22/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 6 | S.dm | -608 | 11.02 | 0 | -55 | | 145 | D | | | | | | | | | | | | | | |
3/5/26 19:06 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 3 | M.dm | 443 | 8.39 | 0 | 53 | 999% | 55 | D | | | | | | | | | | | | | | |
3/5/26 19:06 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 3 | S.dm | -443 | 8.39 | 0 | -53 | | 55 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/4/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Mistras Theodora | PA | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 59 | | 51 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/4/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Le Goff Corinne | PA | O | Chief Co | 1 | M.d | 0 | 0.00 | 0 | 40 | 225 | 57 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Enrietti Andrew | PA | O | See Rema | 1 | M.d | 0 | 0.00 | 0 | 111 | 113 | 208 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Campbell Paul | PA | O | See Rema | 1 | M.dm | 0 | 0.00 | 0 | 209 | 128 | 372 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Scott Andrew | PA | DO | CEO | 1 | M.dm | 0 | 0.00 | 0 | 1,542 | | 1,250 | D | | | | | | | | | | | | | | |
3/5/26 18:55 | 3/4/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | 2 | P | 561 | 1.37 | 0 | 411 | 13 | 3,527 | D | | | | | | | | | | | | | | |
3/5/26 18:55 | 3/3/26 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Williams Sarah Joanne | CA | O | Principa | 1 | S | 0 | 1.06 | 0 | 0 | 0 | 67 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Loscalzo Joseph | CA | D | | 2 | M.dm | 122 | 59.16 | 0 | 2 | 6 | 36 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Loscalzo Joseph | CA | D | | 2 | S.dm | -122 | 59.16 | 0 | -2 | | 36 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Klein Joseph III | CA | D | | 2 | M.d | 2,348 | 62.90 | 0 | 37 | | 11 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Klein Joseph III | CA | D | | 2 | S.d | -2,348 | 62.90 | 0 | -37 | | 11 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Diaz Allene M. | CA | D | | 2 | M.d | 5,956 | 62.56 | 0 | 95 | | 4 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Diaz Allene M. | CA | D | | 2 | S.d | -5,956 | 62.56 | 0 | -95 | | 4 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | 7 | M.d | 9,304 | 58.77 | 0 | 158 | | 27 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | 7 | S.d | -9,304 | 58.77 | 0 | -158 | | 27 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | 7 | M.d | 21,956 | 65.29 | 0 | 336 | | 100 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | 7 | S.d | -21,956 | 65.29 | 0 | -336 | | 100 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | 5 | S.dm | -1,676 | 39.87 | 0 | -42 | | 50 | M | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | 5 | M.dm | 1,676 | 39.87 | 0 | 42 | 516 | 50 | M | | | | | | | | | | | | | | |
3/5/26 17:46 | 3/5/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Carey Stephen P. | MN | O | SVP,CFO | 2 | M.d | 716 | 67.40 | 0 | 11 | 6 | 186 | D | | | | | | | | | | | | | | |
3/5/26 17:46 | 3/5/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Carey Stephen P. | MN | O | SVP,CFO | 2 | S.d | -716 | 67.40 | 0 | -11 | | 186 | D | | | | | | | | | | | | | | |
3/5/26 16:52 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Patel Chintu | NJ | DO | Co-CEO | 1 | M.dm | 0 | 0.00 | 0 | 886 | 4 | 26,142 | D | | | | | | | | | | | | | | |
3/5/26 16:51 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DO | P,Co-CEO | 1 | M.dm | 0 | 0.00 | 0 | 886 | 4 | 22,663 | D | | | | | | | | | | | | | | |
3/5/26 16:37 | 3/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | M.d | 40,153 | 316.17 | 0 | 127 | | 37 | D | | | | | | | | | | | | | | |
3/5/26 16:37 | 3/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | S.d | -40,153 | 316.17 | 0 | -127 | | 37 | D | | | | | | | | | | | | | | |
3/5/26 16:36 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | 13 | S.dm | -39,284 | 314.27 | 0 | -125 | | 639 | D | | | | | | | | | | | | | | |
3/5/26 16:36 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Kurzweil Ray | MD | D | | 2 | M.d | 2,901 | 295.41 | 0 | 10 | 345 | 13 | D | | | | | | | | | | | | | | |
3/5/26 16:36 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Kurzweil Ray | MD | D | | 2 | S.d | -2,901 | 295.41 | 0 | -10 | | 13 | D | | | | | | | | | | | | | | |
3/5/26 16:35 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Thompson Tommy G | MD | D | | 5 | M.d | 1,745 | 122.69 | 0 | 14 | 31 | 60 | D | | | | | | | | | | | | | | |
3/5/26 16:35 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Thompson Tommy G | MD | D | | 5 | S.d | -1,745 | 122.69 | 0 | -14 | | 60 | D | | | | | | | | | | | | | | |
3/5/26 16:34 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Causey Christopher | MD | D | | 8 | M.d | 1,901 | 314.82 | 0 | 6 | | 4 | D | | | | | | | | | | | | | | |
3/5/26 16:34 | 3/4/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Causey Christopher | MD | D | | 8 | S.d | -1,901 | 314.82 | 0 | -6 | | 4 | D | | | | | | | | | | | | | | |
3/5/26 16:32 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Daly Jason B. | NJ | O | EVP,GC | 1 | M.dm | 0 | 0.00 | 0 | 427 | | 252 | D | | | | | | | | | | | | | | |
3/5/26 16:31 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Konidaris Tasos | NJ | O | EVP,CFO | 1 | M.dm | 0 | 0.00 | 0 | 634 | | 449 | D | | | | | | | | | | | | | | |
3/5/26 16:31 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Boyer Andrew S | NJ | O | EVP | 1 | M.dm | 0 | 0.00 | 0 | 549 | | 426 | D | | | | | | | | | | | | | | |
3/5/26 16:30 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Shah Nikita | NJ | O | EVP | 1 | M.dm | 0 | 0.00 | 0 | 508 | | 400 | D | | | | | | | | | | | | | | |
3/5/26 16:29 | 3/3/26 | COLL | Collegium Pharmaceutical, Inc | VA | Health | Drug | Pharmaceutical Preparations | Dreyer Scott | MA | O | EVP,Chie | 3 | S.d | -3,147 | 36.95 | 0 | -85 | | 104 | D | | | | | | | | | | | | | | |
3/5/26 16:27 | 3/5/26 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 13 | M.d | 5,354 | 44.60 | 0 | 120 | | 65 | D | | | | | | | | | | | | | | |
3/5/26 16:27 | 3/5/26 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 13 | S.d | -5,354 | 44.60 | 0 | -120 | | 65 | D | | | | | | | | | | | | | | |
3/5/26 16:16 | 12/18/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 14 | M.dm | 15,647 | 102.75 | 0 | 152 | 34 | 600 | D | | | | | | | | | | | | | | |
3/5/26 16:16 | 12/18/25 | INSM | Insmed Inc | VA | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 14 | S.dm | -15,647 | 102.75 | 0 | -152 | | 600 | D | | | | | | | | | | | | | | |
3/5/26 16:08 | 3/3/26 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Washburn Theodore James Jr. | MA | O | Principa | 1 | S | -152 | 28.88 | 0 | -5 | | 1 | D | | | | | | | | | | | | | | |
3/5/26 16:07 | 3/3/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Amado Rafael | MA | O | See Rema | 3 | S.d | -362 | 8.66 | 0 | -42 | | 52 | D | | | | | | | | | | | | | | |
3/5/26 16:05 | 3/3/26 | HROW | Harrow, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Opaleye Management Inc. | MA | T | | 13 | S.m | -12,533 | 41.49 | 0 | -302 | | 4,346 | I | | | | | | | | | | | | | | |
3/5/26 16:00 | 3/3/26 | INDV | Indivior Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Anderson Woodrow D | VA | O | Chief Ac | 1 | M.d | 0 | 0.00 | 0 | 24 | 999% | 25 | D | | | | | | | | | | | | | | |
3/5/26 16:00 | 3/3/26 | INDV | Indivior Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Preblick Ryan | VA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 87 | 38 | 317 | D | | | | | | | | | | | | | | |
3/5/26 15:59 | 3/3/26 | INDV | Indivior Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burris Jeffrey W | VA | O | GC | 1 | M.d | 0 | 0.00 | 0 | 80 | | 72 | D | | | | | | | | | | | | | | |
3/5/26 15:59 | 3/3/26 | INDV | Indivior Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Heidbreder Christian | VA | O | Chief Sc | 1 | M.d | 0 | 0.00 | 0 | 102 | 70 | 247 | D | | | | | | | | | | | | | | |
3/5/26 11:05 | 3/3/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | 2 | M.d | 551 | 135.50 | 0 | 4 | 14 | 34 | D | | | | | | | | | | | | | | |
3/5/26 11:05 | 3/3/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | | 2 | S.d | -551 | 135.50 | 0 | -4 | | 34 | D | | | | | | | | | | | | | | |
3/5/26 08:00 | 3/4/26 | FBLG | Fibrobiologics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Khoja Hamid | TX | O | CHIEF SC | 1 | P | 11 | 0.3800 | 0 | 30 | 96 | 61 | D | | | | | | | | | | | | | | |
3/4/26 21:04 | 3/2/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Kozarich John W | FL | D | | 3 | S | -274 | 195.33 | 0 | -1 | | 44 | D | | | | | | | | | | | | | | |
3/4/26 20:19 | 3/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Parisi Samuel Joseph | MA | O | VP,Finan | 4 | S.dm | -202 | 11.91 | 0 | -17 | | 15 | D | | | | | | | | | | | | | | |
3/4/26 20:18 | 3/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Nichols Christian Todd | MA | O | SVP,Chie | 4 | S.dm | -180 | 5.96 | 0 | -30 | | 116 | D | | | | | | | | | | | | | | |
3/4/26 20:16 | 3/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 10 | M.dm | 1,125 | 15.38 | 0 | 73 | 361 | 93 | D | | | | | | | | | | | | | | |
3/4/26 20:16 | 3/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 10 | S.dm | -1,125 | 15.38 | 0 | -73 | | 93 | D | | | | | | | | | | | | | | |
3/4/26 20:15 | 3/2/26 | ALKS | Alkermes Plc. | | Health | Drug | Pharmaceutical Preparations | Gaffin David Joseph | MA | O | EVP,CLO, | 4 | S.dm | -120 | 3.68 | 0 | -33 | | 240 | D | | | | | | | | | | | | | | |
3/4/26 19:54 | 3/2/26 | FOLD | Amicus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Campbell Bradley L | NJ | DO | P,CEO | 5 | S.d | -3,335 | 10.40 | 0 | -321 | | 1,130 | D | | | | | | | | | | | | | | |
3/4/26 19:43 | 3/3/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Desjarlais John R | CA | O | SVP,CSO | 4 | S.dm | -2,248 | 13.96 | 0 | -161 | | 270 | D | | | | | | | | | | | | | | |
3/4/26 19:42 | 3/3/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Eckert Celia | CA | O | SVP,GC | 1 | S.d | -18 | 11.89 | 0 | -1 | | 82 | D | | | | | | | | | | | | | | |
3/4/26 19:42 | 3/3/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Dahiyat Bassil I | CA | DO | P,CEO | 3 | S.dm | -3,441 | 13.98 | 0 | -246 | | 568 | D | | | | | | | | | | | | | | |
3/4/26 19:17 | 3/3/26 | VRDN | Viridian Therapeutics, Inc.De | DE | Health | Drug | Pharmaceutical Preparations | Tousignant Jennifer | MA | O | GC | 2 | M.d | 71 | 9.51 | 0 | 7 | | 3 | D | | | | | | | | | | | | | | |
3/4/26 19:15 | 3/3/26 | VRDN | Viridian Therapeutics, Inc.De | DE | Health | Drug | Pharmaceutical Preparations | Harmon Seth | MA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 6 | 411 | 8 | D | | | | | | | | | | | | | | |
3/4/26 19:00 | 3/2/26 | SEPN | Septerna, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaikhly Samira | CA | O | Chief Pe | 2 | M.d | 2,109 | 14.97 | 0 | 141 | | 1 | D | | | | | | | | | | | | | | |
3/4/26 19:00 | 3/2/26 | SEPN | Septerna, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shaikhly Samira | CA | O | Chief Pe | 2 | S.d | -2,109 | 14.97 | 0 | -141 | | 1 | D | | | | | | | | | | | | | | |
3/4/26 18:58 | 3/3/26 | VRDN | Viridian Therapeutics, Inc.De | DE | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | MA | O | COO | 1 | M.d | 0 | 0.00 | 0 | 9 | 244 | 13 | D | | | | | | | | | | | | | | |
3/4/26 18:56 | 3/3/26 | VRDN | Viridian Therapeutics, Inc.De | DE | Health | Drug | Pharmaceutical Preparations | Mahoney Stephen F. | MA | O | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 18 | 124 | 33 | D | | | | | | | | | | | | | | |
3/4/26 18:54 | 3/2/26 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Williams Timothy | DC | O | SVP,GC | 1 | S | -351 | 8.27 | 0 | -42 | | 377 | D | | | | | | | | | | | | | | |
3/4/26 18:53 | 3/2/26 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moran Kevin Patrick | DC | O | SVP,CFO, | 1 | S | -351 | 8.27 | 0 | -42 | | 412 | D | | | | | | | | | | | | | | |
3/4/26 18:52 | 3/2/26 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wijkstrom Joakim | DC | O | SVP,CMO | 1 | S | -255 | 8.27 | 0 | -31 | | 333 | D | | | | | | | | | | | | | | |
3/4/26 18:51 | 3/2/26 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | DC | DOH | P,CEO | 1 | S | -1,277 | 8.17 | 0 | -156 | | 2,704 | D | | | | | | | | | | | | | | |
3/4/26 18:51 | 3/2/26 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Birznieks Gunther | DC | O | SVP,Busi | 1 | S | -351 | 8.27 | 0 | -42 | | 494 | D | | | | | | | | | | | | | | |
3/4/26 18:46 | 3/2/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mutz Christopher | MN | O | HEAD OF | 3 | S | -984 | 77.08 | 0 | -13 | | 104 | D | | | | | | | | | | | | | | |
3/4/26 18:45 | 3/3/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Gutwerg Ori | MN | O | SVP,GENE | 1 | S | -158 | 76.50 | 0 | -2 | | 85 | D | | | | | | | | | | | | | | |
3/4/26 17:50 | 3/2/26 | FBLG | Fibrobiologics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Heeron Pete | TX | DO | CEO | 1 | P.m | 20 | 0.3792 | 0 | 52 | 1 | 5,958 | D | | | | | | | | | | | | | | |
3/4/26 17:44 | 3/3/26 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Okey Stephanie | CA | D | | 1 | S | -119 | 39.67 | 0 | -3 | | 13 | D | | | | | | | | | | | | | | |
3/4/26 17:43 | 3/3/26 | CRNX | Crinetics Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | 1 | S | -266 | 39.67 | 0 | -7 | | 78 | D | | | | | | | | | | | | | | |
3/4/26 17:28 | 3/2/26 | XERS | Xeris Biopharma Holdings, Inc. | | Health | Drug | Pharmaceutical Preparations | Hecht Beth | IL | O | See Rema | 3 | S.d | -352 | 7.04 | 0 | -50 | | 1,308 | D | | | | | | | | | | | | | | |
3/4/26 17:11 | 3/2/26 | RPRX | Royalty Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Coyne Terrance P. | NY | O | EVP,CFO | 6 | S.m | -21,645 | 41.48 | 0 | -522 | | 621 | I | | | | | | | | | | | | | | |
3/4/26 16:55 | 3/2/26 | IRON | Disc Medicine, Inc. | | Health | Drug | Pharmaceutical Preparations | Savage William Jacob | MA | O | Chief Me | 4 | S.d | -1,916 | 71.32 | 0 | -27 | | 93 | D | | | | | | | | | | | | | | |
3/4/26 16:40 | 3/2/26 | KNSA | Kiniksa Pharmaceuticals International, Plc | | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 2 | M.d | 2,207 | 27.59 | 0 | 80 | | 61 | D | | | | | | | | | | | | | | |
3/4/26 16:40 | 3/2/26 | KNSA | Kiniksa Pharmaceuticals International, Plc | | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 2 | S.d | -2,207 | 27.59 | 0 | -80 | | 61 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dananberg Jamie | CA | O | Chief Me | 2 | S | -59 | 5.27 | 0 | -11 | | 124 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Overdorf Michael | CA | O | EVP,CHIE | 2 | S | -55 | 5.23 | 0 | -11 | | 183 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yednock Ted | CA | O | EVP,CHIE | 2 | S | -70 | 5.24 | 0 | -13 | | 154 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Artis Dean Richard | CA | O | EVP,CHIE | 2 | S | -59 | 5.27 | 0 | -11 | | 180 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | 2 | S | -70 | 5.24 | 0 | -13 | | 171 | D | | | | | | | | | | | | | | |
3/4/26 16:30 | 3/2/26 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smethurst Dominic | MA | O | Chief Me | 2 | S | -77 | 8.23 | 0 | -9 | | 96 | D | | | | | | | | | | | | | | |
3/4/26 16:28 | 3/2/26 | STOK | Stoke Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Krainer Adrian R. | MA | D | | 1 | S | -287 | 39.66 | 0 | -7 | | 317 | D | | | | | | | | | | | | | | |
3/4/26 16:24 | 3/3/26 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Cozadd Bruce C | L2 | D | | 1 | S | -1,119 | 186.44 | 0 | -6 | | 406 | D | | | | | | | | | | | | | | |
3/4/26 16:21 | 3/2/26 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Liu Joy | MA | O | EVP,GC | 1 | S | -442 | 495.96 | 0 | -1 | | 23 | D | | | | | | | | | | | | | | |
3/4/26 16:17 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leonard Keith R | CA | D | | 2 | M.d | 1,322 | 16.84 | 0 | 79 | | 24 | D | | | | | | | | | | | | | | |
3/4/26 16:17 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leonard Keith R | CA | D | | 2 | S.d | -1,322 | 16.84 | 0 | -79 | | 24 | D | | | | | | | | | | | | | | |
3/4/26 16:16 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | 3 | S | -797 | 26.55 | 0 | -30 | | 70 | D | | | | | | | | | | | | | | |
3/4/26 16:00 | 3/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Klee Justin B. | MA | DO | Co-CEO | 5 | S.dm | -4,129 | 10.57 | 0 | -391 | | 3,379 | D | | | | | | | | | | | | | | |
3/4/26 16:00 | 3/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohen Joshua B | MA | DO | Co-CEO | 5 | S.dm | -4,129 | 10.57 | 0 | -391 | | 3,379 | D | | | | | | | | | | | | | | |
3/4/26 16:00 | 3/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bedrosian Camille L | MA | O | Chief Me | 1 | S | -94 | 14.58 | 0 | -6 | | 169 | D | | | | | | | | | | | | | | |
3/4/26 16:00 | 3/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Frates James M | MA | O | CFO | 3 | S | -204 | 13.78 | 0 | -15 | | 304 | D | | | | | | | | | | | | | | |
3/4/26 16:00 | 3/2/26 | AMLX | Amylyx Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazzariello Gina | MA | O | GC | 3 | S | -198 | 14.46 | 0 | -14 | | 145 | D | | | | | | | | | | | | | | |
3/3/26 21:32 | 3/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 2 | M.d | 138 | 27.57 | 0 | 5 | 5 | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:32 | 3/3/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 2 | S.d | -138 | 27.57 | 0 | -5 | | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:31 | 2/2/26 | SYRE | Spyre Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 3 | S | -1,585 | 35.22 | 0 | -45 | | 672 | D | | | | | | | | | | | | | | |
3/3/26 20:43 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Edwards Larry Todd | CA | O | See Rema | 2 | S.d | -145 | 25.30 | 0 | -6 | | 175 | D | | | | | | | | | | | | | | |
3/3/26 20:42 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | 2 | S.d | -1,446 | 25.29 | 0 | -57 | | 1,019 | D | | | | | | | | | | | | | | |
3/3/26 20:42 | 2/27/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | 2 | S.dm | -1,341 | 25.45 | 0 | -53 | | 137 | D | | | | | | | | | | | | | | |
3/3/26 20:42 | 3/2/26 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vairavan Latha | CA | O | SVP CFO | 2 | S.d | -106 | 25.28 | 0 | -4 | | 88 | D | | | | | | | | | | | | | | |
3/3/26 20:41 | 12/15/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 6 | M.dm | 1,001 | 21.33 | 0 | 47 | 63 | 121 | D | | | | | | | | | | | | | | |
3/3/26 20:41 | 12/15/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | 6 | S.dm | -1,001 | 21.33 | 0 | -47 | | 121 | D | | | | | | | | | | | | | | |
3/3/26 20:20 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Shroff Eric | IL | O | SVP | 1 | S | -82 | 115.58 | 0 | -1 | | 39 | D | | | | | | | | | | | | | | |
3/3/26 20:10 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Salvadori Daniel Gesua Sive | IL | O | EVP,GROU | 1 | S | -102 | 115.58 | 0 | -1 | | 146 | D | | | | | | | | | | | | | | |
3/3/26 20:06 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Morrone Louis H. | IL | O | EVP | 1 | S | -132 | 115.58 | 0 | -1 | | 77 | D | | | | | | | | | | | | | | |
3/3/26 20:05 | 3/2/26 | GNLX | Genelux Corp | DE | Health | Drug | Pharmaceutical Preparations | Thomas John | CA | D | | 1 | S | -29 | 2.90 | 0 | -10 | | 483 | D | | | | | | | | | | | | | | |
3/3/26 20:04 | 3/1/26 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Estepan Ian Michael | MA | O | COO | 3 | M.d | 396 | 13.78 | 0 | 29 | 16 | 205 | D | | | | | | | | | | | | | | |
3/3/26 20:02 | 3/1/26 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodino-Klapac Louise | MA | O | P,R,D,Te | 1 | M.d | 0 | 0.00 | 0 | 8 | 4 | 228 | D | | | | | | | | | | | | | | |
3/3/26 20:00 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Moreland Mary K | IL | O | EVP | 1 | S | -71 | 115.58 | 0 | -1 | | 116 | D | | | | | | | | | | | | | | |
3/3/26 19:55 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | McCoy John A. Jr. | IL | O | VP,CONTR | 1 | S | -68 | 115.58 | 0 | -1 | | 25 | D | | | | | | | | | | | | | | |
3/3/26 19:39 | 3/2/26 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Cushman Elizabeth C. | IL | O | EVP,GC,S | 1 | S | -30 | 115.58 | 0 | 0 | | 39 | D | | | | | | | | | | | | | | |
3/3/26 19:09 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pinion John Richard | CA | O | See Rema | 1 | S | -229 | 22.80 | 0 | -10 | | 110 | D | | | | | | | | | | | | | | |
3/3/26 19:08 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Erik | CA | O | EVP,Chie | 1 | S | -240 | 22.80 | 0 | -11 | | 90 | D | | | | | | | | | | | | | | |
3/3/26 19:06 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kakkis Emil D | CA | DO | P,CEO | 1 | S | -1,240 | 22.80 | 0 | -54 | | 2,818 | D | | | | | | | | | | | | | | |
3/3/26 18:51 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Parschauer Karah Herdman | CA | O | EVP,GC | 1 | S | -185 | 22.80 | 0 | -8 | | 76 | D | | | | | | | | | | | | | | |
3/3/26 18:51 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Huizenga Theodore Alan | CA | O | SVP,Chie | 2 | S | -40 | 23.37 | 0 | -2 | | 50 | D | | | | | | | | | | | | | | |
3/3/26 18:50 | 3/2/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Horn Howard | CA | O | CFO | 4 | S.m | -484 | 25.01 | 0 | -19 | | 95 | D | | | | | | | | | | | | | | |